NCT03475186 2026-03-13
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Wake Forest University Health Sciences
Phase 2 Completed
Clinical Trials
14 trialsNCT06723015 2025-11-18
Tau PET Outcomes With Anti-amyloid Immunotherapies
Mayo Clinic
Phase 2 Enrolling by invitation
NCT06727773 2025-09-02
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Recruiting
NCT06136546 2025-05-07
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Massachusetts General Hospital
Phase 2 Recruiting
NCT03186638 2023-09-25
Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer
University of Rochester
Phase 2 Completed
NCT04092647 2023-06-15
Ashwagandha for Cognitive Dysfunction
Sutter Health
Phase 2 Unknown
NCT04447846 2023-05-25
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2 Completed
NCT04033419 2023-04-20
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT02970500 2023-03-23
CogMet
CHU de Quebec-Universite Laval
Phase 2 Terminated
NCT04104113 2020-06-16
HERBAL
National University of Singapore
Phase 2 Unknown
NCT03356769 2020-06-09
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03191968 2019-12-20
BOOST
University of Illinois at Urbana-Champaign
Phase 2 Completed
NCT00495703 2017-04-04
TACTIC
Vanderbilt University Medical Center
Phase 2 Completed
NCT02600299 2016-09-22
Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment
National University of Singapore
Phase 2 Completed